#$%^&*AU2020202650A120200514.pdf#####Abstract: Title: Pharmaceutical Composition 5 A pharmaceutical composition is described. The composition comprises: (i) a drug component comprising at least one tiotropium compound selected from tiotropium and the pharmaceutically acceptable derivatives thereof; and (ii) a propellant component comprising 1,1-difluoroethane (HFA-152a).